NET PROFIT (x1000 EUR)
EMPLOYEES
Empros Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-931
|
-825
|
-1,160 |
EBITDA |
-1,053
|
-828
|
-1,161 |
Total assets |
13,272
|
6,889
|
5,638 |
Current assets |
3,027
|
709
|
562 |
Current liabilities |
643
|
429
|
142 |
Equity capital |
12,629
|
6,460
|
5,496 |
- share capital |
16
|
14
![]() |
14 |
Employees (average) |
8
|
7
![]() |
7 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
95.2%
|
93.8%
|
97.5% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-7.0%
|
-12.0%
|
-20.6% |
Current ratio |
470.8%
|
165.3%
|
395.8% |
Return on equity (ROE) |
-7.4%
|
-12.8%
|
-21.1% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
1
|
0
|
1 |
Chg. No. of employees % |
14%
|
0%
|
17% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.